In a study performed by Tan et al. in 2004 on 84 samples of glioma using immunohistochemistry, it was demonstrated that there is a significant difference in the expression of cyclin D1 between high-grade glioma and low-grade glioma. This evidence concerns the gene CCND1 and glioma.